316 related articles for article (PubMed ID: 11921656)
21. MMX mesalamine.
Baker DE
Rev Gastroenterol Disord; 2006; 6(3):146-52. PubMed ID: 16957657
[TBL] [Abstract][Full Text] [Related]
22. Clinical trial: randomized-controlled clinical study comparing the efficacy and safety of a low-volume vs. a high-volume mesalazine foam in active distal ulcerative colitis.
Eliakim R; Tulassay Z; Kupcinskas L; Adamonis K; Pokrotnieks J; Bar-Meir S; Lavy A; Mueller R; Greinwald R; Chermesh I; Gross V;
Aliment Pharmacol Ther; 2007 Nov; 26(9):1237-49. PubMed ID: 17944738
[TBL] [Abstract][Full Text] [Related]
23. [Ulcerative colitis. Complementary therapies].
Matthes H; Moser G; Jantschek G
Z Gastroenterol; 2004 Sep; 42(9):1031-2. PubMed ID: 15455282
[No Abstract] [Full Text] [Related]
24. Ulcerative colitis associated with leukocytoclastic vasculitis of the skin.
Tripodi Cutrì F; Salerno R; Lo Schiavo A; Gravina AG; Romano M; Ruocco E
Dig Liver Dis; 2009 Jul; 41(7):e42-4. PubMed ID: 18799375
[TBL] [Abstract][Full Text] [Related]
25. [Interstitial nephritis associated with mesalazine therapy].
Vuotila M; Ikäheimo R; Pietiläinen T
Duodecim; 2003; 119(20):1978-82. PubMed ID: 14640003
[No Abstract] [Full Text] [Related]
26. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.
Levine DS; Riff DS; Pruitt R; Wruble L; Koval G; Sales D; Bell JK; Johnson LK
Am J Gastroenterol; 2002 Jun; 97(6):1398-407. PubMed ID: 12094857
[TBL] [Abstract][Full Text] [Related]
27. Combined oral and topical mesalazine treatment for extensive ulcerative colitis.
Moss AC; Cheifetz AS; Peppercorn MA
Nat Clin Pract Gastroenterol Hepatol; 2006 May; 3(5):290-3. PubMed ID: 16673009
[TBL] [Abstract][Full Text] [Related]
28. Folic acid and sulfasalazine for colorectal carcinoma chemoprevention in patients with ulcerative colitis: the old and new evidence.
Diculescu M; Ciocîrlan M; Ciocîrlan M; Piţigoi D; Becheanu G; Croitoru A; Spanache S
Rom J Gastroenterol; 2003 Dec; 12(4):283-6. PubMed ID: 14726972
[TBL] [Abstract][Full Text] [Related]
29. Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study.
D'Haens G; Hommes D; Engels L; Baert F; van der Waaij L; Connor P; Ramage J; Dewit O; Palmen M; Stephenson D; Joseph R
Aliment Pharmacol Ther; 2006 Oct; 24(7):1087-97. PubMed ID: 16984503
[TBL] [Abstract][Full Text] [Related]
30. [Interstitial pneumonia related to mesalamine].
Lamsiah T; Moudden K; Baaj M; Hadri L
Gastroenterol Clin Biol; 2010 Mar; 34(3):224-6. PubMed ID: 20299168
[TBL] [Abstract][Full Text] [Related]
31. Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis.
Bantel H; Berg C; Vieth M; Stolte M; Kruis W; Schulze-Osthoff K
Am J Gastroenterol; 2000 Dec; 95(12):3452-7. PubMed ID: 11151876
[TBL] [Abstract][Full Text] [Related]
32. Dose escalation of 5ASA: does it work?
Travis SP
Dig Liver Dis; 2005 Feb; 37(2):82-4. PubMed ID: 15733517
[No Abstract] [Full Text] [Related]
33. Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis.
Frieri G; Pimpo M; Galletti B; Palumbo G; Corrao G; Latella G; Chiaramonte M; Caprilli R
Dig Liver Dis; 2005 Feb; 37(2):92-6. PubMed ID: 15733520
[TBL] [Abstract][Full Text] [Related]
34. [Mesalazine granules instead of tablets. New ulcerative colitis therapy confirmed also in general practice routine].
MMW Fortschr Med; 2004 Jun; 146(24):53. PubMed ID: 15366501
[No Abstract] [Full Text] [Related]
35. [Peripheral eosinophilia in ulcerative colitis: apropos of a case].
Galofre N; Fuste L; Oriol A; Grau J
Gastroenterol Hepatol; 1997 Mar; 20(3):163. PubMed ID: 9162539
[No Abstract] [Full Text] [Related]
36. [Once daily mesalazine for long-term remission. Ulcerative colitis: maintenance therapy becomes easier].
MMW Fortschr Med; 2008 Mar; 150(11):44-5. PubMed ID: 18447278
[No Abstract] [Full Text] [Related]
37. Mesalazine (5-aminosalicylic acid) micropellets show similar efficacy and tolerability to mesalazine tablets in patients with ulcerative colitis--results from a randomized-controlled trial.
Raedler A; Behrens C; Bias P
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1353-63. PubMed ID: 15606398
[TBL] [Abstract][Full Text] [Related]
38. Ulcerative colitis treatment for children and teens.
FDA Consum; 2007; 41(2):5. PubMed ID: 17582854
[No Abstract] [Full Text] [Related]
39. [Maintaining remission of ulcerative colitis with the probiotic Escherichia Coli Nissle 1917 is as effective as with standard mesalazine].
Adam B; Liebregts T; Holtmann G
Z Gastroenterol; 2006 Mar; 44(3):267-9. PubMed ID: 16514573
[No Abstract] [Full Text] [Related]
40. A double-blind dose-escalating trial comparing novel mesalazine pellets with mesalazine tablets in active ulcerative colitis.
Marakhouski Y; Fixa B; Holomán J; Hulek P; Lukas M; Bátovský M; Rumyantsev VG; Grigoryeva G; Stolte M; Vieth M; Greinwald R;
Aliment Pharmacol Ther; 2005 Jan; 21(2):133-40. PubMed ID: 15679762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
